-+ 0.00%
-+ 0.00%
-+ 0.00%
Theriva Biologics Holds Special Stockholder Meeting
Share
Listen to the news
Theriva Biologics Holds Special Stockholder Meeting
  • Theriva Biologics shareholders approved increasing authorized common stock to 500,000,000 shares at a special meeting on November 18, 2026.
  • The board retains discretion over implementing the amendment and may elect not to proceed.
  • Shareholders also ratified prior approval for issuance of up to 16,184,560 common shares upon exercise of common stock purchase warrants.
  • Adjournment was approved but proved unnecessary because both substantive proposals passed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-129752), on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending